Combimist L Inhaler
Utilized to manage bronchospasm to alleviate respiratory distress.
Strengths: 50/20mcg
Where to Check Availability
Medicine details
- Alternative names
Combivent
- Therapeutic class
Bronchodilator
- Pharmacological class
Beta2-agonist; Antimuscarinic
- Contraindications
hypersensitivity to levosalbutamol; hypersensitivity to ipratropium bromide
- Precautions and warnings
use with caution in narrow-angle glaucoma; may cause paradoxical bronchospasm
- Minor side effects
tremor; dry mouth
- Moderate side effects
tachycardia; palpitations
- Serious side effects
anaphylaxis — requires immediate medical attention
- Dosage forms
Pressurised inhalation, solution
- Administration route
Inhalation use
- Patient summary
Utilized to manage bronchospasm to alleviate respiratory distress.
- Prescription status
POM
- Manufacturer
Boehringer Ingelheim
- Onset Time
5–15 minutes
- Duration
4–6 hours
- Storage instructions
Store below 25°C, away from extreme heat.
- Drug interactions
beta-blockers
- Age restrictions
Consult physician for paediatric use.
Mechanism of action
A combination of a short-acting beta2-agonist and an anticholinergic bronchodilator to relax airways and increase airflow to the lungs.
Pregnancy and breastfeeding
Pregnancy: Only used if the clinical benefit outweighs the risk. Breastfeeding: Data is insufficient.
Combimist L Inhaler
Utilized to manage bronchospasm to alleviate respiratory distress.
Editorial Notes
- Active ingredient(s): Levosalbutamol, Ipratropium Bromide
- Listed indication(s): Chronic Obstructive Pulmonary Disease, Asthma